BlackRock Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
Other funds holding SCMP
KAM
BFA
RA
BIT
RI
BlackRock Advisors's SCMP Position: Q4 2016 in Review
BlackRock Advisors reduced its Sucampo Pharmaceuticals, Inc. (SCMP) stake by 18% in Q4 2016, selling an estimated $331K and leaving 111,434 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1645.
BlackRock Advisors first reported a position in SCMP in Q2 2013 and has held it in 15 quarters since. The position peaked at $8.16M in Q2 2015. 165 funds tracked by Wall St. Rank hold SCMP as of Q4 2016.
- BlackRock Advisors held 111,434 shares of Sucampo Pharmaceuticals, Inc. worth $1.51M as of Q4 2016.
- BlackRock Advisors sold 23,712 Sucampo Pharmaceuticals, Inc. shares in Q4 2016, an estimated $331K.
- Sucampo Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1645 holding.
- BlackRock Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
- BlackRock Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $8.16M in Q2 2015.
- 165 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2016.
Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.